Literature DB >> 8348949

Increase in number of bone marrow macrophages in patients with myelodysplastic syndromes.

M Kitagawa, R Kamiyama, T Kasuga.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348949     DOI: 10.1111/j.1600-0609.1993.tb00608.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  5 in total

Review 1.  Oxidative stress and the myelodysplastic syndromes.

Authors:  Morag J Farquhar; David T Bowen
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

2.  p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia.

Authors:  M Kitagawa; S Yoshida; T Kuwata; T Tanizawa; R Kamiyama
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

3.  A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure.

Authors:  Amer M Zeidan; Hanna A Knaus; Tara M Robinson; Andrea M H Towlerton; Edus H Warren; Joshua F Zeidner; Amanda L Blackford; Amy S Duffield; David Rizzieri; Mark G Frattini; Yair M Levy; Mark A Schroeder; Anna Ferguson; Katherine E Sheldon; Amy E DeZern; Ivana Gojo; Steven D Gore; Howard Streicher; Leo Luznik; B Douglas Smith
Journal:  Clin Cancer Res       Date:  2018-05-01       Impact factor: 12.531

Review 4.  Bone marrow niches in myeloid neoplasms.

Authors:  Masanobu Kitagawa; Morito Kurata; Iichiroh Onishi; Kouhei Yamamoto
Journal:  Pathol Int       Date:  2019-11-10       Impact factor: 2.534

Review 5.  Acquired myelodysplasia or myelodysplastic syndrome: clearing the fog.

Authors:  Ethan A Natelson; David Pyatt
Journal:  Adv Hematol       Date:  2013-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.